Companies: 10,795·Total market cap: $144.5T
Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc.

COLLNASDAQHealthcare● Active
$33.27
$-0.11(-0.33%)
Market Cap$1.1B
P/E Ratio
52W High$50.787
52W Low$29.08
Overview

Collegium Pharmaceutical, Inc. (COLL) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

COLL · shares outstanding · updated Jun 8, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
31.7M -1.76% YoY Change
FY · as of Dec 31, 2025 · Reported in USD
vs 32.3M in FY 2024
Diluted Shares Outstanding
39.7M
incl. options, RSUs, convertibles
Dilution Spread
+25.22%
Diluted vs Basic
YoY Change
-1.76%
year-over-year
Float (Free Float)
31.8M
publicly tradable shares
98.0% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-08

Shares Outstanding Growth Rate

3-Year CAGRdeclining
-2.1%
2022 → 2025
5-Year CAGRdeclining
-1.6%
2020 → 2025
10-Year CAGRincreasing
+8.9%
2015 → 2025

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2025Latest
Diluted Shares: 39.7M
31.7M
-1.76%
FY 2024
Diluted Shares: 40.4M
32.3M
-4.35%
FY 2023
Diluted Shares: 41.8M
33.7M
-0.26%
FY 2022
Diluted Shares: 33.8M
33.8M
-3.17%
FY 2021
Diluted Shares: 41.0M
34.9M
+1.54%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs COLL
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+>999%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+>999%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+>999%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+>999%
#7
Collegium Pharmaceutical, Inc.COLL
Collegium Pharmaceutical, Inc.YOU
31.7M

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Collegium Pharmaceutical, Inc. (COLL) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2025, Collegium Pharmaceutical, Inc. reports 31.7M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Collegium Pharmaceutical, Inc.'s basic shares outstanding (31.7M) represents currently issued shares. Diluted shares outstanding (39.7M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +25.22%.

Shares Outstanding vs. Float (Free Float)

Collegium Pharmaceutical, Inc.'s float is 31.8M (98.0% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float31.8M(98.0%)
Outstanding32.4M

Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

Collegium Pharmaceutical, Inc. (COLL) shares outstanding history from 2013 to 2025. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Collegium Pharmaceutical, Inc. shares outstanding for the fiscal year ending December 31, 2025 were 31.7M, a 1.76% decline year-over-year. Collegium Pharmaceutical, Inc. FY 2025 shares outstanding were 31.7M, a -1.76% decline from FY 2024.

Collegium Pharmaceutical, Inc. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +8.9% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.

Frequently asked questions

COLL shares outstanding · 4 questions

As of December 31, 2025, Collegium Pharmaceutical, Inc. (COLL) has approximately 31.7M basic shares outstanding and 39.7M diluted shares outstanding. This represents a -1.76% year-over-year change from FY 2024 (32.3M). Collegium Pharmaceutical, Inc.'s declining share count is primarily driven by its share buyback program. For the complete historical data table, see the history table above.

COLL shares outstandinghow many shares does COLL haveCOLL basic shares 2025COLL diluted shares

Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Collegium Pharmaceutical, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-08